| Literature DB >> 33218871 |
K Bruce-Hickman1, K Fan2, F Plaat2, S Sheth2.
Abstract
Entities:
Mesh:
Year: 2020 PMID: 33218871 PMCID: PMC7564509 DOI: 10.1016/j.ijoa.2020.10.005
Source DB: PubMed Journal: Int J Obstet Anesth ISSN: 0959-289X Impact factor: 2.603
Outcomes prior to and during the COVID-19 pandemic
| Prior to pandemic | During pandemic | ||
|---|---|---|---|
| Deliveries total, n | 868 | 858 | - |
| Mode of delivery | |||
| Spontaneous vaginal | 488 (56.2) | 420 (49.0) | 0.01 |
| Operative vaginal | 112 (12.9) | 133 (15.5) | |
| Caesarean | 268 (30.9) | 305 (35.5) | |
| Caesarean urgency | |||
| Category 1 | 16 (6.0) | 19 (6.2) | 0.33 |
| Category 2 | 77 (28.7) | 109 (35.7) | |
| Category 3 | 31 (11.6) | 31 (10.2) | |
| Category 4 | 144 (53.7) | 146 (47.9) | |
| General anaesthesia, total, n | 14 | 6 | – |
| Caesarean delivery | 10 (3.7) | 6 (2.0) | |
| Category 1 | 4 (25.0) | 1 (5.3) | |
| Category 2-3 | 3 (2.8) | 2 (1.4) | |
| Category 4 | 3 (2.1) | 3 (2.1) | |
| Other | 4 | 0 |
Data presented as n or n (%). P-values are calculated using the chi-square test.
Percentages are of the total number of caesarean deliveries.
Percentages are of the total number of general anaesthetics in each category of caesarean delivery.